Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.
Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.
复制标题
DOI:
10.1021/ol101482h
复制
发表时间:
2010-10-15
期刊:
影响因子:
5.2
通讯作者:
Seley-Radtke KL
中科院分区:
文献类型:
--
作者:
Wauchope OR;Tomney MJ;Pepper JL;Korba BE;Seley-Radtke KL
Promising biological activity in a number of therapeutic areas has been reported for both tricyclic nucleosides and 2′-modified nucleosides. In particular, di-substitution at the C-2′ position of nucleosides has resulted in significant activity against the Hepatitis C virus (HCV). Combining this with the observation that tricyclic nucleosides developed in our laboratory have been shown to inhibit the RNA-dependent RNA polymerase NS5B led to the design of a series of 2′-modified tricyclic nucleosides. Details of the synthesis, structural characterization and preliminary biological results are reported.
登录
查看更多内容
影响因子:
4.8
作者:
Qin, WP;Luo, H;Murakami, S
通讯作者:
Murakami, S
影响因子:
3.6
作者:
NIEDBALLA, U;VORBRUGGEN, H
通讯作者:
VORBRUGGEN, H
影响因子:
7.3
作者:
Clark, JL;Hollecker, L;Pankiewiez, KW
通讯作者:
Pankiewiez, KW
影响因子:
2.1
作者:
Zhang Z;Wauchope OR;Seley-Radtke KL
通讯作者:
Seley-Radtke KL
影响因子:
3.6
作者:
Seley, KL;Zhang, L;Quirk, S
通讯作者:
Quirk, S